Swedish medtech company IRRAS is to raise SKr217m (US$22.3m) in a fully underwritten rights issue to help commercialise its products. It is selling 37.5 million shares at SKr5.80 per share…
Swedish medtech company IRRAS is to raise SKr217m (US$22.3m) in a fully underwritten rights issue to help commercialise its products. It is selling 37.5 million shares at SKr5.80 per share…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


